Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/01/2007CA2649029A1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
11/01/2007CA2648895A1 Camptothecin-analog with a novel, "flipped" lactone-stable, e-ring and methods for making and using same
11/01/2007CA2648813A1 Organic compounds
11/01/2007CA2648810A1 Organic compounds
11/01/2007CA2648809A1 Indazole compounds and methods for inhibition of cdc7
11/01/2007CA2648741A1 Purine derivatives as a2a receptor agonists
11/01/2007CA2648729A1 Indole amide derivatives as ep4 receptor antagonists
11/01/2007CA2648578A1 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them
11/01/2007CA2648291A1 Swellable particles for drug delivery
11/01/2007CA2648037A1 Organic compounds
11/01/2007CA2647893A1 Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom
11/01/2007CA2647677A1 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/01/2007CA2647087A1 Paediatric amino acid solution for parenteral nutrition
11/01/2007CA2647077A1 Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonists
11/01/2007CA2646678A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/01/2007CA2646667A1 Methods of treating hot flashes with formulations for transdermal or transmucosal application
11/01/2007CA2646652A1 Substituted pyrazinone derivatives for use as a medicine
11/01/2007CA2646638A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
11/01/2007CA2646446A1 Pharmaceutical compositions for promoting wound healing
11/01/2007CA2646313A1 Stereoselective reduction of a morphinone
11/01/2007CA2646206A1 Transdermal delivery system comprising sufentanil and its analogues
11/01/2007CA2645633A1 Combinations of therapeutic agents for treating cancer
11/01/2007CA2644425A1 Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
11/01/2007CA2639070A1 Novel tumour suppressor
11/01/2007CA2629223A1 Glucagon receptor antagonists, preparation and therapeutic uses
10/2007
10/31/2007EP1849872A1 Adeno-associated virus vectors and uses thereof
10/31/2007EP1849830A1 Finely divided composition containing poorly water soluble substance
10/31/2007EP1849802A2 Methods for altering fertility
10/31/2007EP1849797A2 Peptidomimetic protease inhibitors
10/31/2007EP1849796A1 Anti-penicillin resistant pneumococci agent and novel 16-membered ring macrolide derivative
10/31/2007EP1849795A1 1-substituted-7-( -d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same
10/31/2007EP1849785A1 N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors
10/31/2007EP1849784A1 Indoline-substituted pyrazoline compounds, their preparation and use as medicaments
10/31/2007EP1849783A1 Octahydropentalene-substituted pyrazoline compounds, their preparation and use as medicaments
10/31/2007EP1849782A1 Quinolinone derivatives as tyrosine kinase inhibitors
10/31/2007EP1849780A1 Vaccine against nicotine addiction
10/31/2007EP1849777A1 Process for obtaining a valsartan salt useful for obtaining valsartan
10/31/2007EP1849776A1 Azepane- or Azocane-substituted pyrazoline compounds, their preparation and use as medicaments
10/31/2007EP1849775A1 Cycloalkane-substituted pyrazoline compounds, their preparation and use as medicaments
10/31/2007EP1849774A1 CYCLOHEPTA(b)PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME
10/31/2007EP1849773A1 Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative
10/31/2007EP1849772A1 Bicyclic tetrahydropyrrole compounds
10/31/2007EP1849771A1 Bicyclic tetrahydropyrrole compounds
10/31/2007EP1849762A1 Substituted biphenyl carboxylic acids and derivatives thereof
10/31/2007EP1849760A1 Ether compounds, compositions, and uses thereof
10/31/2007EP1849480A2 Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
10/31/2007EP1849478A2 Inflammatory mediator antagonists
10/31/2007EP1849475A1 Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependent diabetes
10/31/2007EP1849474A1 Antimicrobial peptide and use thereof
10/31/2007EP1849471A1 Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and S-adenosylmethionine
10/31/2007EP1849470A1 Anticancer drug containing alpha, alpha, alphatrifluorothymidine and thymidine phosphorylase inhibitor
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1849468A2 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
10/31/2007EP1849467A1 The synergistically pharmaceutical composition of baicalein and baicalin for inhibiting tumor
10/31/2007EP1849466A2 Infusion fluid for dialysis patients
10/31/2007EP1849465A1 Agent for controlling function of gpr34 receptor
10/31/2007EP1849463A2 Microbial cellulose materials for use in transdermal drug delivery systems, methods of manufacture and use
10/31/2007EP1849462A2 A method of alleviating signs and symptons of Spasticity
10/31/2007EP1849459A1 Ezetimibe compositions
10/31/2007EP1849456A1 Use of a 4-aminopiperidine derivative as agent for inducing and/or stimulating the growth of keratin fibres and/or preventing their loss
10/31/2007EP1849455A1 Use of a 4-aminopiperidine derivative as agent for inducing and/or stimulating the growth of keratin fibres and/or preventing their loss
10/31/2007EP1849434A1 Coating for stents
10/31/2007EP1848806A1 Anti-t cell and autoantigen treatment of autoimmune disease
10/31/2007EP1848803A2 Rnai-mediated inhibition of ocular hypertension targets
10/31/2007EP1848802A1 Compounds
10/31/2007EP1848749A2 Contact drug delivery system
10/31/2007EP1848741A1 Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats o11 serotype
10/31/2007EP1848728A1 Ibandronate polymorph a
10/31/2007EP1848723A1 New isothiazoloquinolones and related compounds as anti-infective agents
10/31/2007EP1848722A1 Amorphous taclolimus solid dispersion having an enhanced solubility and pharmaceutical composition comprising same
10/31/2007EP1848721A1 Chemical compounds
10/31/2007EP1848719A1 [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
10/31/2007EP1848718A1 Inhibitors of e1 activating enzymes
10/31/2007EP1848717A2 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy
10/31/2007EP1848716A1 Crystalline form of an indazole-carboxamide compound
10/31/2007EP1848715A1 Compounds having tie2 (tek) inhibitory activity
10/31/2007EP1848712A1 Atm inhibitors
10/31/2007EP1848710A2 Heterocyclic substituted piperazines with cxcr3 antagonist activity
10/31/2007EP1848709A1 Novel salt form of a dopamine agonist
10/31/2007EP1848708A1 Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders
10/31/2007EP1848707A1 Awthranilic acid derivatives and their use in treatment of diseases of lipid metabolism, in particular dyslipidaemia
10/31/2007EP1848704A1 Novel tubulin polymerisation inhibitors
10/31/2007EP1848703A2 Compounds and methods for modulating communication and virulence in quorum sensing bacteria
10/31/2007EP1848700A1 5- [4- (4- (2 -amino- 2 -methoxycarbonylethyl) phenoxy) benzilidene]thiazolidin-2 , 4-dion e derivatives and related compounds for reducing glucose, cholesterol and triglyceride levels in plasma
10/31/2007EP1848699A1 Anthranilic acid derivatives as hm74a receptor agonists
10/31/2007EP1848698A2 Quinoxaline derivatives as antitumor agents
10/31/2007EP1848697A2 Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase
10/31/2007EP1848696A1 Imidazole and benzimidazole derivates useful as histamine h3 antagonists
10/31/2007EP1848695A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
10/31/2007EP1848693A1 Indan-amide derivatives with glycogen phosphorylase inhibitory activity
10/31/2007EP1848689A1 Crystals of ladostigil tartrate, methods of production and pharmaceutical compositions thereof
10/31/2007EP1848687A1 Inhibitors of diacylglycerol acyltransferase (dgat)
10/31/2007EP1848686A2 9-substituted tetracyclines
10/31/2007EP1848685A1 11a, 12-derivatives of tetracycline compounds
10/31/2007EP1848684A1 Ester-linked gemini surfactant compounds for use in gene therapy
10/31/2007EP1848506A2 Pyrimidine-fused diazepine derivatives and indole-fused pteridines
10/31/2007EP1848504A2 Wound treatment device for photodynamic therapy and method of using same
10/31/2007EP1848466A2 Mri contrast agents for diagnosis and prognosis of tumors
10/31/2007EP1848455A1 Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
10/31/2007EP1848454A1 Methods for treating lymphomas using a combination of a chemotherapeutic agent and il-2 and optionally an anti-cd20 antibody
1 ... 3522 3523 3524 3525 3526 3527 3528 3529 3530 3531 3532 3533 3534 3535 3536 3537 3538 3539 3540 3541 3542 ... 7860